To hear about similar clinical trials, please enter your email below
Trial Title:
Breast Cancer Survivor Educational Intervention
NCT ID:
NCT05700396
Condition:
Breast Cancer
Breast Neoplasms
Breast Carcinoma
Breast Cancer Female
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Breast Cancer
Breast Neoplasms
Breast Carcinoma
Breast Cancer Female
Breast cancer survivor
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Breast Cancer Survivor Education Program
Description:
Weekly sessions via Zoom platform with study staff.
Arm group label:
Breast Cancer Survivor Education Program
Summary:
The goal of this study is to test a 6-week virtual education program among Black breast
cancer survivors. The virtual program includes sessions on physical activity, goal
setting, nutrition, sleep, stress, and social connections.
Detailed description:
This six-week feasibility study will evaluate a virtual support and education program
among up to 15 Black female breast cancer survivors. Participants will be asked to attend
a 90 minute group session once a week for 6 weeks and complete surveys pre and post
intervention surveys to ascertain study endpoints. This study is supported by funding
from Pfizer and in-kind support from the American Cancer Society, Inc.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Female
- Self-identified Black or African American race
- Age 22-79
- Diagnosis of Stage I, II, or III invasive breast cancer
- Completed active treatment at least 6 months ago, but within the past five years
- Speaks English
Exclusion Criteria:
- Undergoing active treatment (i.e., surgery, chemotherapy, radiation)
- Undergoing evaluation for suspected recurrence
Gender:
Female
Gender based:
Yes
Minimum age:
22 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Massachusetts General Hospital Cancer Center
Address:
City:
Boston
Zip:
02215
Country:
United States
Status:
Recruiting
Contact:
Last name:
Erica Warner, MPH, ScD
Phone:
617-724-9516
Email:
ewarner@mgh.harvard.edu
Start date:
February 28, 2023
Completion date:
December 31, 2023
Lead sponsor:
Agency:
Massachusetts General Hospital
Agency class:
Other
Collaborator:
Agency:
American Cancer Society, Inc.
Agency class:
Other
Collaborator:
Agency:
Pfizer
Agency class:
Industry
Source:
Massachusetts General Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05700396
